Document is current

Any future updates will be listed below

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

Crossref DOI link: https://doi.org/10.1038/bjc.2015.98

Published Online: 2015-03-24

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark